Envestnet Asset Management Inc Can Fite Bio Pharma Ltd. Transaction History

Envestnet Asset Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 02, 2021	SELL	$1.66 - $2.15 $23,563 - $30,519	-14,195 Closed	0 $0
Q3 2020 Oct 09, 2020	BUY	$1.61 - $2.67 $3,176 - $5,267	1,973 Added 16.14%	14,195 $25,000
Q2 2020 Jul 08, 2020	BUY	$1.28 - $2.5 $15,644 - $30,555	12,222 New	12,222 $24,000

1.1K

Ticker CANF
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,191,500
Market Cap $42.1M
Description
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinic...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.